Company news
Genix Pharmaceuticals Corporation (TSXV:GENX) news
Genix Pharmaceuticals Corporation news releases on 6ix. Latest, May 5, 2026: Genix Pharmaceuticals Announces Change To CFO
Press releases & updates
Genix Pharmaceuticals Announces Change To CFO
May 5, 2026
Genix Pharmaceuticals Issues Clarification to Previously Announced Private Placement Terms
October 7, 2025
Genix Pharmaceuticals Closes Private Placement
September 4, 2025
Genix Announces TSX-V Approval of Warrant Amendments
February 6, 2024
Genix Announces Warrant Repricing and Seeks Extension
January 18, 2024
Genix Announces AGM Results
May 26, 2023
Genix Receives Approval to Extend Warrants from the TSX Venture Exchange
July 28, 2022
Genix Proposes to Extend Warrants
July 20, 2022
Genix Pharmaceuticals Corp. Receives Approval for Drug Establishment License
July 15, 2021
Genix Pharmaceuticals Corp. Lists on the OTCQB Venture Market Exchange
June 21, 2021
Genix Pharmaceuticals Corporation Provides a Corporate Update to Shareholders
June 7, 2021
Genix Pharmaceuticals Corporation Enters into Exclusive License and Supply Agreement for Canada's First Generic Thyroid Medication
April 1, 2021
Genix Pharmaceuticals Corporation Prepares to File Abbreviated New Drug Submissions (ANDS) for Its First Ten Ophthalmic Drugs with Health Canada
March 22, 2021
Genix Pharmaceuticals Corporation Announces AGM Results and Welcomes New Director
September 22, 2020
Genix Pharmaceuticals Corporation Announces Closing of Second Tranche Financing and Closing of Acquisition of Rights to Nutraceutical Products Sucanon(R) and Renochlor(R)
August 6, 2020
Genix Pharmaceuticals Corporation Announces Closing of Initial Tranche of Over Subscribed Non-Brokered Private Placement
July 17, 2020
Genix Pharmaceuticals Corporation Announces the Extension of Payment Terms for the Acquisitions of Rights to Renochlor(R), Sucanon(R) and Flu-x(TM)
June 29, 2020
Genix Pharmaceuticals Corporation Announces Non-Brokered Private Placement
June 22, 2020
Genix Pharmaceuticals Corporation Enters into a Definitive Agreement to Acquire Global Rights to Flu-X(R)
March 27, 2020
Genix Pharmaceuticals Corporation Completes Purchase of Rights to 30 Ophthalmic Generic Drugs and Product Dossiers
February 14, 2020
IIROC Trading Resumption - GENX
January 15, 2020
Genix Acquires Exclusive Rights to SUCANON(R) and RENOCHLOR(R)
January 14, 2020
Genix Pharmaceuticals Corporation Agrees To Purchase 30 Ophthalmic Generic Drug Dossiers And Enters Into LOI To Acquire 2 Additional Nutraceutical Products
December 22, 2019
IIROC Trading Halt - GENX
October 29, 2019
ALTA Announces Name Change to Genix Pharmaceuticals Corporation
June 18, 2019
Alta Natural Herbs & Supplements Appoints Board Member
June 5, 2019
Alta Natural Herbs & Supplements Appoints New Officers and Board of Directors
March 11, 2019
Investment Industry Regulatory Organization of Canada - Trade Resumption - ALTA NATURAL HERBS & SUPPLEMENTS LTD. - AHS
June 9, 2009
TSX Venture Exchange - Cease Trade Order
March 9, 2009
Market Regulation Services - Trade Resumption - Alta Natural Herbs & Supps - AHS
September 27, 2007
Market Regulation Services - Trading Halt - Alta Natural Herbs & Supplements Ltd. - AHS
August 22, 2007